Biochemistry is a phage-producing company which is aimed at maximizing the long-term experience of phagicides in order to simplify the fight against bacterial infections. SavvY created a financial model for a new production unit of Biochimpharm and evaluated the existing project: its investment volume, assumptions, profitability, cost, and revenue structure. Using a 5-year financial model, the company’s project was assessed reliably for investors.

BCP.jpg

Biochimpharm

small_Biochimpharm.png

thumbnail_Biochimpharm.png

Biochimpharm.png

<ul><li style="text-align:justify;">Investment Appraisal – To make prudent and savvy financial decisions regarding your investment opportunities. The financial model enables you to assess revenue and expenditure streams and alternative business development scenarios.</li><li style="text-align:justify;">Access to Finance –&nbsp;To create the best possible tool for funding opportunities for your various investment applications (loan, grant, equity).</li><li style="text-align:justify;">Business Expansion –&nbsp;To serve as a stepping stone instrument to financially evaluate your business development strategy.</li></ul><img src="/uploads/Slide5_55ab99e428.PNG" alt="Slide5.PNG">

When you need us

We create a well-designed, automated analytical spreadsheet. By maintaining a high client engagement, we tailor the main assumptions depending on the pattern of the business concept to structure the financial model. The spreadsheet contains scenarios and sensitivity analysis considering clients’&nbsp;needs. SavvY is flexible to fit varied modeling approaches: using the client's expertise or starting from scratch with industrial assumptions and competitors' analysis. Through this financial tool, we offer a continuous value that can be successfully utilized even after the project period.

Biochimpharm Financial Model